ClinicalTrials.gov
ClinicalTrials.gov Menu

A Pilot Study of Vaccination With Epitope-Enhanced TARP Peptide and TARP Peptide-Pulsed Dendritic Cells in the Treatment of Stage D0 Prostate Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00972309
Recruitment Status : Completed
First Posted : September 4, 2009
Last Update Posted : September 18, 2018
Sponsor:
Information provided by:
National Institutes of Health Clinical Center (CC)